Search

Search Constraints

You searched for: Author/Creator Gillespie, Kate

Search Results

5. Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition. Issue 1 (December 2017)